BIAF bioAffinity Technologies Inc.

USD 2.76 0.40 16.949153
Icon

bioAffinity Technologies Inc. (BIAF) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.76

+0.40 (+16.95)%

USD 0.02B

0.44M

N/A

N/A

Icon

BIAF

bioAffinity Technologies Inc. (USD)
COMMON STOCK | NSD
USD 2.76
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 2.76

bioAffinity Technologies Inc. (BIAF) Stock Forecast

N/A

Based on the bioAffinity Technologies Inc. stock forecast from 0 analysts, the average analyst target price for bioAffinity Technologies Inc. is not available over the next 12 months. bioAffinity Technologies Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of bioAffinity Technologies Inc. is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, bioAffinity Technologies Inc.’s stock price was USD 2.76. bioAffinity Technologies Inc.’s stock price has changed by +4.15% over the past week, +45.26% over the past month and +76.92% over the last year.

No recent analyst target price found for bioAffinity Technologies Inc.
No recent average analyst rating found for bioAffinity Technologies Inc.

Company Overview bioAffinity Technologies Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lun...Read More

22211 West Interstate 10, San Antonio, TX, United States, 78257

14

December

USD

USA

Adjusted Closing Price for bioAffinity Technologies Inc. (BIAF)

Loading...

Unadjusted Closing Price for bioAffinity Technologies Inc. (BIAF)

Loading...

Share Trading Volume for bioAffinity Technologies Inc. Shares

Loading...

Compare Performance of bioAffinity Technologies Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIAF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To bioAffinity Technologies Inc. (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc -6.50 (-1.31%) USD44.10B 52.65 36.72

ETFs Containing BIAF

Symbol Name BIAF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About bioAffinity Technologies Inc. (BIAF) Stock

Stock Target Advisor's fundamental analysis for bioAffinity Technologies Inc.'s stock is Bearish.

Unfortunately we do not have enough data on BIAF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIAF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIAF's stock to indicate if its overvalued.

The last closing price of BIAF's stock was USD 2.76.

The most recent market capitalization for BIAF is USD 0.02B.

Unfortunately we do not have enough analyst data on BIAF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains bioAffinity Technologies Inc.'s stock.

As per our most recent records bioAffinity Technologies Inc. has 14 Employees.

bioAffinity Technologies Inc.'s registered address is 22211 West Interstate 10, San Antonio, TX, United States, 78257. You can get more information about it from bioAffinity Technologies Inc.'s website at https://www.bioaffinitytech.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...